(4-(Thiazolidine-3-carbonyl)phenyl)boronic acid, 98%, 1g

Diethyl 2-(((2-methoxypyridin-3-yl)amino)methylene)malonate, 95%, 1g

Methyl 2-Hydroxy-3-nitrobenzoate, 97.0%, 500g

N,N-Diethylchloroacetamide>98.0%(GC)25g

7-Chlorochroman-4-ol, 98%, 250mg

5-Ethyluracil>98.0%(HPLC)(T)5g

4-(5-amino-1,3,4-oxadiazol-2-yl)-1-phenylpyrrolidin-2-one, 95.0%, 250mg

Adamantane-2-carboxylic acid, 95.0%, 2.5g

Ácido gálico, mínimo 98 %, pa, ACS, anhidro, 500 g, envase de vidrio

(1-(TRIFLUOROMETHYL)-1H-PYRAZOL-4-YL)BORONIC ACID, 95%, 5g

trans-tert-Butyl 4-aminocyclohexanecarboxylate, 97.0%, 5g

2-{[(2-fluorophenyl)sulfonyl]amino}-4-(methylthio)butanoic acid, 95.0%, 2.5g

2-Bromo-6-methylbenzoic Acid>98.0%(GC)(T)5g